The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Update on Legislation, Advocacy Efforts to Advance Rheumatology

Update on Legislation, Advocacy Efforts to Advance Rheumatology

September 1, 2014 • By Joseph Flood, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

It appears funding the federal government and budget appropriations will again be managed by continuing resolutions. This creates yet another perennial problem for NIH funding. Although about half of NIH sequester cuts were eventually rolled back, funding is still below pre-sequester levels, and it appears the NIH will be funded near the same level as last year. We all know that this is unacceptable. It seriously jeopardizes the U.S. medical research enterprise. The important work of many of our members is threatened.

You Might Also Like
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • Congress Can Begin Work to Advance Rheumatology Before New Year
  • Rheumatology Advocacy Starts at Home
Explore This Issue
September 2014
Also By This Author
  • President’s Perspective: The ACR’s RISE Registry Will Simplify Reporting, Comparing Clinical Data

We will continue to fight for restoration and increases in NIH funding. We also hope that new solutions are adopted by Congress, such as Senator Tom Harkin’s introduction of the Accelerating Biomedical Research Act. This forward-thinking proposal would increase NIH funding by exempting it from traditional budget caps.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Also not addressed by Congress were cuts to Part B drug reimbursements. The ACR is addressing Medicare reimbursement cuts by partnering with oncologists to support H.R. 1416, which would reverse sequester cuts to Part B drugs and reimburse lost monies. Although taking a piece-by-piece approach to the sequester has been an unpopular approach with many Democrats, we remain optimistic that our persistence will prevail.

State & Local Advocacy

We must advocate at all levels of government, and as I have described before, the ACR has increased its focus on issues primarily decided at the state level. We are working with state rheumatology societies. Under the leadership of the Affiliate Society Council chaired by Angus Worthing, MD, and, of course, with the help of our very capable staff, I have been proud to sign dozens of letters on behalf of the ACR. We are pushing bills in an expanding number of states to address state issues, including biosimilars, specialty tiers, step therapy and prior authorization.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

You Are Key to These Efforts

I am proud of our progress this year, and I hope you are, too. As we enter the election season and the end of this congressional session, there is reason for optimism. But the next several months will be critical. We need your involvement and your support for RheumPAC if you are a U.S.-based ACR or ARHP member. Please encourage your colleagues to learn more about RheumPAC and how they can lend their support at the ACR website.*

RheumPAC has proved itself a powerful effector arm of ACR advocacy policy, and we need members’ support to make it stronger. Visit the ACR’s Legislative Action Center at www.rheumatology.org/advocacy to read more about the issues and the many ways you can make a personal difference as you help us with Advancing Rheumatology! Don’t hesitate to call upon the ACR’s staff as you make your own mark in these critical areas affecting your practices and patients.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Billing/Coding, Biologics & Biosimilars, Drug Updates, Legislation & Advocacy, Practice Management, President's Perspective, Professional Topics, Quality Assurance/Improvement Tagged With: AC&R, Advocacy, American College of Rheumatology, ARHP, Association of Rheumatology Health Professionals, Billing, Biologics, Biosimilars, Coding, drug, ICD-10, Legislation, Medicare, Practice Management, Research, rheumatologist, SGR, TechnologyIssue: September 2014

You Might Also Like:
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • Congress Can Begin Work to Advance Rheumatology Before New Year
  • Rheumatology Advocacy Starts at Home
  • Much at Stake for Rheumatology in Lame Duck Session of Congress

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.